This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 29 from Patent US 5831002
General Information
DRACP ID DRACP01548
Peptide Name Sequence 29 from Patent US 5831002
Sequence XVPP
Sequence Length 4
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification X=Xaa
Chiral L
Physicochemical Information
Formula C15H23N3O3
Absent amino acids ACDEFGHIKLMNQRSTWY
Common amino acids P
Mass 45705
Pl 6.11
Basic residues 0
Acidic residues 0
Hydrophobic residues 1
Net charge 0
Boman Index 404
Hydrophobicity 25
Aliphatic Index 72.5
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 5831002 A
Patent Title Antitumor peptides.
Other Iinformation Granted Patent Family: 92s / 92ex; Family Jurisdictions: AU, BR, EP, DK, RO, KR, SI, JP, CA, HU, CZ, DE, NZ, AT, NO, AR, MX, WO, SK, IL, CO, BG, MY, UA, PL, TR, ES, CN, PT, HR, TW, ZA, US; Legal Status: Expired; Application No: 47245395; Filed:Jun 7, 1995; Published: Nov 3, 1998; Earliest Priority: May 20, 1992; Granted: Nov 3, 1998
Other Published ID CA2219818A1 CA2219818C CA2219819A1 CA2219819C CN1182153C CN1182154C CN1187198A CN1187199A DE69623472D1 DE69623472T2 DE69623992D1 DE69623992
This work is licensed under a Creative Commons Attribution 4.0 International License.